The UCSF Center for Vulnerable Populations (CVP) at San Francisco General Hospital (SFGH) continues to receive recognition for its innovative research that advances health communication to prevent and treat chronic diseases in patients at risk.
In the July issue of Nature , a team of researchers at UCSF, Jerusalem and Portugal announced that they have identified a gene, Chd1, that is required for embryonic stem cells to keep their all-purpose, pluripotent state.
President Barack Obama awarded stem cell faculty member Jeremy Reiter, MD, PhD a Presidential Early Career Award for Scientists and Engineers. Dr. Reiter was one of twelve awardees selected by the President’s White House Office of Science and Technology.
Thanks to the very generous support of longtime supporters, Bob and Michelle Friend, a new Endowed Chair in the Diabetes Center has been created. Selected as the recipient of the Robert B. Friend and Michelle M. Friend Endowed Chair in Diabetes Research is Mark Anderson, MD, PhD.
When Greg Szot arrived at UCSF nearly a decade ago from the University of Chicago, he was on a mission to accelerate the field of pancreatic islet transplantation to assist those living with type 1 diabetes.
If you are a parent/caregiver of a child with diabetes, the UCSF Pediatric Diabetes Department hopes your child’s return to school this month has gone smoothly. All families are urged to meet with the school nurse and all staff who supervise your child to educate them about your child’s diabetes care needs and establish protocol for delivery of medical orders.
Does someone in your family have type 1 diabetes? If so, other family members may be at risk for developing diabetes. UCSF is offering a free simple blood test for relatives of people with type 1 diabetes. The test could detect an increased risk for type 1 diabetes up to ten years before symptoms appear.
In August, UCSF’s Mary Sullivan, RN, MSN, C-ANP, CDE received the Diabetes Educator of the Year Award at the American Association of Diabetes Educators (AADE) Annual Convention in Atlanta. This national award sponsored by LifeScan, Inc. honors a diabetes educator who has made a special contribution to the field through dedication, innovation and sensitivity in patient care.
Diabetes Center/QB3 researcher and San Francisco General Hospital endocrinologist, Feroz Papa, MD, PhD, has uncovered a new class of drugs that may prevent death of stressed cells, a mechanism that is thought to underlie diseases such as type 2 diabetes.
Significant progress has been made in the past several years in improving the results of pancreatic islet transplantation for patients with type 1 diabetes. Here at UCSF, we are pursuing three studies that we hope will help patients with diabetes who suffer from hypoglycemic unawareness and poor glucose control.
Our UCSF research and clinical care employees are a recognized strength of the Diabetes Center. They are igniting innovation, accelerating the pace of scientific discovery, and shaping the future of science and health.
In a series of studies featured recently in the journal Diabetes Care, Dean Schillinger, MD and his team reported success in developing and evaluating an automated telephone self-management support system to reduce diabetes-related health inequalities in vulnerable populations.
Chinese Americans are 1.6 times more likely than European Americans to develop type 2 diabetes. Since San Francisco has one of the oldest and largest Chinese communities in the U.S., UCSF is helping to test the effectiveness of culturally specific diabetes management programs for Chinese Americans.